Share Your Perspective: EAHAD Survey on Gene Therapy in Haemophilia Care
European Association for Haemophilia and Allied Disorders (EAHAD) shared an inviting post on LinkedIn:
“Gene therapy brings exciting possibilities for people with haemophilia, but effective care depends on how well healthcare professionals understand, discuss, and integrate it into practice.
We’re conducting a Europe-wide survey to explore current understanding, clinical experience, and decision-making around gene therapy among physicians, nurses, physiotherapists, psychologists, and all professionals involved in haemophilia care.
Your input will help identify educational needs, support better patient communication, and strengthen shared decision-making in clinical practice.”
Your perspective matters, take the survey here.
Stay updated on the emerging with Hemostasis Today.
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies
-
Jul 12, 2026, 06:12Precision in Antithrombotic Therapy at ISTH 2026 – The Lancet Haematology
-
Jul 11, 2026, 23:36Emmanuel J Favaloro: A Fresh Perspective on the Manual Tilt Tube Method for PT and INR Determination